However, Di et al. detected low expression of CD4+ and CD8+ T cells specific for OCT4 in the blood and ascites of ovarian cancer patients, which may reflect another mechanism by which ovarian tumors evade immune surveillance (Di et al., 2013). The gene discussed is POU5F1; the disease is ovarian neoplasm.